Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis


Ozkan T. B. , Mistik R., Dikici B., Nazlioglu H. O.

BMC GASTROENTEROLOGY, vol.7, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7
  • Publication Date: 2007
  • Doi Number: 10.1186/1471-230x-7-9
  • Title of Journal : BMC GASTROENTEROLOGY

Abstract

Background: Neonatal hepatitis refers to a heterogeneous group of disorders, caused by many factors including cytomegalovirus infection, revealing similar morphologic changes in the liver of an infant less than 3 months of age. Approximately 40% of cholestasis in infants is due to neonatal hepatitis. It may cause latent or acute cholestatic or chronic hepatitis, including cirrhosis in immunocompetant infant.